Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1945 3
1946 1
1947 5
1948 6
1949 5
1950 10
1951 14
1952 5
1953 14
1954 27
1955 19
1956 19
1957 11
1958 16
1959 28
1960 22
1961 17
1962 20
1963 48
1964 80
1965 48
1966 65
1967 104
1968 103
1969 116
1970 102
1971 120
1972 157
1973 114
1974 115
1975 95
1976 96
1977 94
1978 110
1979 109
1980 116
1981 105
1982 138
1983 158
1984 148
1985 190
1986 172
1987 180
1988 213
1989 259
1990 264
1991 251
1992 285
1993 329
1994 437
1995 469
1996 413
1997 507
1998 559
1999 548
2000 578
2001 586
2002 542
2003 605
2004 707
2005 750
2006 896
2007 918
2008 1102
2009 1361
2010 1605
2011 1848
2012 2179
2013 2368
2014 2673
2015 2969
2016 3059
2017 3342
2018 3479
2019 3771
2020 4046
2021 4579
2022 4472
2023 4312
2024 4541
2025 5156
2026 3587

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66,806 results

Results by year

Filters applied: . Clear all
Page 1
Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies.
Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A, Mokhtari K, Shahpasand K, Farahani N, Meybodi TE, Entezari M, Taheriazam A, Hushmandi K, Hashemi M. Pouyan A, et al. Mol Cancer. 2025 Feb 26;24(1):58. doi: 10.1186/s12943-025-02267-0. Mol Cancer. 2025. PMID: 40011944 Free PMC article. Review.
Glioblastoma multiforme (GBM) is the most prevalent and aggressive primary brain tumor in adults, characterized by a poor prognosis and significant resistance to existing treatments. ...
Glioblastoma multiforme (GBM) is the most prevalent and aggressive primary brain tumor in adults, characterized by a poor prog …
Current Immunotherapies for Glioblastoma Multiforme.
Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H. Huang B, et al. Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. eCollection 2020. Front Immunol. 2021. PMID: 33767690 Free PMC article. Review.
Glioblastoma multiforme (GBM) is the most common and aggressive malignant tumor found in the central nervous system. ...
Glioblastoma multiforme (GBM) is the most common and aggressive malignant tumor found in the central nervous system. ...
Glioblastoma multiforme.
Alexander E Jr. Alexander E Jr. Surg Neurol. 1985 Jan;23(1):82-3. doi: 10.1016/0090-3019(85)90165-x. Surg Neurol. 1985. PMID: 2981122 No abstract available.
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
Batash R, Asna N, Schaffer P, Francis N, Schaffer M. Batash R, et al. Curr Med Chem. 2017;24(27):3002-3009. doi: 10.2174/0929867324666170516123206. Curr Med Chem. 2017. PMID: 28521700 Review.
BACKGROUND: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, with an incidence of 3.19 cases per 100,000 person years and remarkably poor prognosis showing a 5-year survival rate of 4-5%, and only a 26-33% survival rate at 2 years in c …
BACKGROUND: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, with an incidence of 3.19 cases pe …
Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
Liao W, Fan S, Zheng Y, Liao S, Xiong Y, Li Y, Liu J. Liao W, et al. Curr Med Chem. 2019;26(31):5862-5874. doi: 10.2174/0929867325666180514113136. Curr Med Chem. 2019. PMID: 29768997 Review.
Glioblastoma Multiforme (GBM) is the most frequent glioma with a poor prognosis. The mainstay treatment for GBM is chemotherapy, but the average survival of GBM remains unsatisfactory due to therapeutic resistance. Poor permeability restricted by the Blood Brain Bar …
Glioblastoma Multiforme (GBM) is the most frequent glioma with a poor prognosis. The mainstay treatment for GBM is chemotherap …
[Glioblastoma multiforme].
Biernat W. Biernat W. Pol J Pathol. 2001;52(4 Suppl):23-8. Pol J Pathol. 2001. PMID: 11987610 Review. Polish. No abstract available.
Glioblastoma multiforme metastatic to lung in the absence of intracranial recurrence: case report.
Kumaria A, Teale A, Kulkarni GV, Ingale HA, Macarthur DC, Robertson IJA. Kumaria A, et al. Br J Neurosurg. 2022 Apr;36(2):290-292. doi: 10.1080/02688697.2018.1529296. Epub 2018 Nov 19. Br J Neurosurg. 2022. PMID: 30450987 Review.
We present the case of a 65 year old gentleman who underwent craniotomy and debulking of a left temporal glioblastoma multiforme (GBM). Post-operatively he received chemotherapy and radiotherapy with good response demonstrated on interval MRI scans. ...
We present the case of a 65 year old gentleman who underwent craniotomy and debulking of a left temporal glioblastoma multiforme …
Immunological Insights into Photodynamic Therapy of Glioblastoma Multiforme.
Woźnicki P, Bartusik-Aebisher D, Przygórzewska A, Aebisher D. Woźnicki P, et al. Molecules. 2025 Jul 24;30(15):3091. doi: 10.3390/molecules30153091. Molecules. 2025. PMID: 40807266 Free PMC article. Review.
The Gliomas account for 81% of all malignant central nervous system tumors and are classified by WHO into four grades of malignancy. Glioblastoma multiforme (GBM), the most common grade IV glioma, exhibits an extremely aggressive phenotype and a dismal five-year sur …
The Gliomas account for 81% of all malignant central nervous system tumors and are classified by WHO into four grades of malignancy. Glio …
Reoperation for Recurrent Glioblastoma Multiforme.
Robin AM, Lee I, Kalkanis SN. Robin AM, et al. Neurosurg Clin N Am. 2017 Jul;28(3):407-428. doi: 10.1016/j.nec.2017.02.007. Neurosurg Clin N Am. 2017. PMID: 28600015 Review.
The role of reoperation for glioblastoma multiforme (GBM) recurrence is currently unknown. However, multiple studies have indicated that survival and quality of life are improved with a repeat operation at the time of disease recurrence. ...
The role of reoperation for glioblastoma multiforme (GBM) recurrence is currently unknown. However, multiple studies have indi …
66,806 results
You have reached the last available page of results. Please see the User Guide for more information.